Ponatinib circumvents all types of imatinib resistance in chronic myelogenous leukemia cell lines
- PMID: 23673326
- DOI: 10.4161/cc.24982
Ponatinib circumvents all types of imatinib resistance in chronic myelogenous leukemia cell lines
Keywords: BCR-ABL; T315I mutation; TKI; chronic myelogenous leukemia; dasatinib; imatinib; nilotinib; ponatinib; resistance.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous